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Summary Solid tumours develop an acidic extracellular environment with high concentration of lactic acid, and lactic acid produced by
glycolysis has been assumed to be the major cause of tumour acidity. Experiments using lactate dehydrogenase (LDH)-deficient ras-
transfected Chinese hamster ovarian cells have been undertaken to address directly the hypothesis that lactic acid production is responsible
for tumour acidification. The variant cells produce negligible quantities of lactic acid and consume minimal amounts of glucose compared with
parental cells. Lactate-producing parental cells acidified lightly-buffered medium but variant cells did not. Tumours derived from parental and
variant cells implanted into nude mice were found to have mean values of extracellular pH (pHe) of 7.03 ± 0.03 and 7.03 ± 0.05, respectively,
both of which were significantly lower than that of normal muscle (pHe = 7.43 ± 0.03; P < 0.001). Lactic acid concentration in variant tumours
(450 ± 90 ,ug g-1 wet weight) was much lower than that in parental tumours (1880 ± 140 gg/g-1) and similar to that in serum (400 ± 35 ,ug/g-1).
These data show discordance between mean levels of pHe and lactate content in tumours; the results support those of Newell et al (1993)
and suggest that the production of lactic acid via glycolysis causes acidification of culture medium, but is not the only mechanism, and is
probably not the major mechanism responsible for the development of an acidic environment within solid tumours.
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Measurements of extracellular pH (pHe) in tumours, mainly by
insertion of microelectrodes, have shown that the mean pHe of
tumours is, on average, about 0.5 pH units lower than that of
normal tissue (Wike-Hooley et al, 1984; Vaupel et al, 1989; Gillies
et al, 1994). There is considerable heterogeneity in the distribution
of pHe, both within and between tumours with mean tumour pHe
of about 6.9-7.0, compared with a mean pHe in normal tissue of
about 7.4. Nutrient-deprived microregions of tumours might be
expected to have values of pHe lower than the mean, and recent
work suggests that lower values of pHe are found distant from
tumour blood vessels (Martin and Jain, 1994; Helmlinger et al,
1997). Although pHe in solid tumours tends to be acidic, measure-
ments of intracellular pH (pHi) by 3'P-NMR spectroscopy have
shown no significant differences in mean pHi (-7.2) between solid
tumours and normal tissues (Vaupel et al, 1989; Negendank,
1992). These results indicate that cells in many solid tumours are
actively regulating their pHi to physiological levels.
As solid tumours enlarge, deficient vascularization often results
in poor delivery of nutrients, including oxygen, to many regions
within them and poor clearance of metabolic products of cells
(Tannock, 1968; Vaupel et al, 1989). Cells in a hypoxic microenvi-
ronment are dependent on glycolysis for a source of ATP, leading
to the production of large amounts of lactic acid; in addition,
tumour cells often use the glycolytic pathway to produce lactate
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even under aerobic conditions. Most solid tumours appear to have
a high concentration of lactic acid in their extracellular fluid,
compared with normal tissues (e.g. Gullino et al, 1964; Mueller-
Klieser et al, 1988), and glycolytic activity resulting in lactic acid
production has been assumed to be the main cause of tumour
acidity.
The hypothesis that lactic acid is the major cause of tumour
acidity has been supported by evidence showing a correlation
between increasing lactic acid content and decreasing pHe in
tumours (Kallinowski et al, 1989). Furthermore, the systemic
administration ofglucose to humans and rodents, which stimulates
production of lactic acid, has been shown to result in a decrease in
tumour pHe (Jahde and Rajewsky, 1982; Thistlethwaite et al,
1987; Reinhold et al, 1991). However, recent studies of tumours
grown from variant cells that are glycolysis deficient (because of
decreased glucose uptake and phosphoglucose isomerase defi-
ciency) and that produce negligible amounts oflactic acid showed
that these tumours also had an acidic microenvironment (Newell et
al, 1993). Values of pHe and lactate concentration have also been
studied during periods of vascular clamping and reperfusion of an
experimental tumour (Parkins et al, 1997). The initial fall in the
pHe in the avascular tumour correlated with lactate production, but
the subsequent continued fall in pHe did not.
The above results suggest that the production of lactic acid via
glycolysis is not the only cause of tumour acidity and that addi-
tional or alternative causes oftumour acidity exist. To address this
hypothesis we have performed experiments on variant cells with a
different metabolic phenotype; these cells were selected to be defi-
cient in lactate dehydrogenase (LDH) activity and therefore did
not produce lactate (Stamato and Jones, 1977). Ourresults indicate
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that tumours grown from LDH-deficient cells have values of pHe
as low as those in tumours grown from parental cells, even though




The variant cells were derived originally from the parental CHO
cell line using a nylon cloth replica plating method (Stamato and
Jones, 1977). The parental and LDH-deficient variant cells were
transfected subsequently with the H-ras oncogene by calcium
phosphate precipitation using a construct that included the neoR
gene; the transfected cells were selected in G418 and cloned.
Mycoplasma-free cells were grown as monolayers in a-minimum
essential medium (a-MEM) supplemented with 0.1 mg ml' of
kanamycin and 10% fetal bovine serum (FBS). For experiments,
exponentially growing cells were detached from flasks using
0.05% trypsin in 0.53 mM EDTA (Gibco). Cell lines were
reinitiated from frozen stocks every 2-3 months.
In vitro experiments
Glucose consumption, production of lactic acid, pyruvate and
carbon dioxide were measured in vitro. Cells were trypsinized,
washed with phosphate buffered saline (PBS), resuspended at 106
cells ml in a-MEM with 10% FBS and incubated in humidified
95% air + 5% carbon dioxide. The concentration oflactic acid and
glucose was determined on samples of cell-free a-MEM using
commercial assay kits (826-A and 16-10 respectively, Sigma)
with a spectrophotometer (Cary 219; Varian). To measure intra-
cellular and extracellular pyruvate, cells at 106 cells ml-' in a-
MEM with 10% FBS were incubated for up to 24 h. After varying
duration of incubation, the reaction was stopped with cold
perchloric acid, cells were detached mechanically from culture
dishes and homogenized in the same medium. The homogenate
was centrifuged for 5 min at 200g to remove debris. Pyruvate
content was determined in the supernatant using a commercial
assay kit (726, Sigma).
To measure the pH ofthe exposure medium, cells (1 x 106 ml-')
were placed in a-MEM lightly buffered with 1 mM Hepes to pH
7.4 and gassed with humidified 100% air or 100% nitrogen.
Change in pH ofthe medium was monitored using a pH electrode
(Radiometer, Copenhagen) and a pH meter (model PMH82,
Radiometer).
Total production of carbon dioxide was measured using a
commercial assay kit (131-A, Sigma). Cells were trypsinized,
washed and resuspended at 5 x 106 cells ml' in bicarbonate-free
a-MEM with dialysed 10% FBS buffered with 1 mm Hepes. Two
millilitres ofthis cell suspension were placed in a glass vial, which
was then sealed. Two hours later, 0.2 ml of4 N sulphuric acid was
added to displace carbon dioxide from the suspension and carbon
dioxide was trapped in 0.1 ml of5% potassium hydroxide that was
placed in a small plastic dish attached to the side ofthe glass vial.
Bicarbonate in the potassium hydroxide solution was measured
using the assay kit.
In order to evaluate carbon dioxide release from glucose or
alanine via the Krebs cycle, a method was adapted from Vanes et
al (1984). Trypsinized cells were resuspended in Ringer's solution
containing 5.6 mm glucose and 10% FBS at 5 x 106 cells ml'. Two
millilitres of these cell suspensions were placed in glass vials and
an Eppendorf tube containing a Whatman filter paper (GF/C)
impregnated with 0.1 ml of 5% potassium hydroxide was
attached to the sidewall of the glass vial. Eight microlitres
of [6-'4C]glucose (56 mCi mmol-') or 8 ,l of [U-'4C]alanine
(152 mCi mmol-', Amersham) were added to the cell suspension
and the vials were sealed. Two hours later, 0.2 ml of4 N sulphuric
acid was added to displace carbon dioxide from the suspensions.
Suspensions were stirred for an additional hour. Filter papers were
removed and allowed to dry overnight. Filters were assayed in
5 ml of liquid scintillant (Amersham) using a scintillation counter
(LS330:Beckman). Parallel experiments showed that the recovery
of 14CO2 from labelled sodium carbonate (50 mCi mmol-1) added
to buffer and then acidified was 86%.
Generation and characterization of tumours
Parental or variant cells (1 x 107) were injected initially into the
left hind leg of athymic female Swiss nude (nu/nu) mice. The
resulting tumours were excised, and single-cell suspensions
were obtained by enzymatic digestion with trypsin (Difco) and
DNAase I (Sigma). Cells were plated in a-MEM + 10% FBS.



















Figure 1 Concentration of lactic acid (A), glucose (B) and change in pHe
(C) in medium containing parental (-, D) and variant cells (0, 0) exposed
to aerobic (open symbols) or hypoxic conditions (closed symbols). Cells
(106 ml-1) were placed in a-MEM + 10% FBS buffered with 1 mm Hepes for
measurement of pHe. Symbols indicate mean ± s.e. from three experiments
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from respective tumours were injected subcutaneously on the
dorsum ofnude mice in a 50% solution ofMatrigel (Fridman et al,
1991). Growth of tumours was monitored using a calliper. The
diameter of tumours was then converted to an estimate of tumour
weight by using a previously defined calibration curve.
The proportion of necrosis was measured in first generation
tumours grown in the left hind leg and second generation tumours
grown on the dorsum of the mice. Tumours were removed,
sectioned and stained with haematoxylin and eosin. The propor-
tion of necrosis in tumours was estimated using stereoscopic
microscopy.
In order to determine whether there had been any tendency for
reversion of the LDH-deficient phenotype, second-generation
tumours were excised and cells were obtained by enzymatic diges-
tion. The cells were grown in culture, and lactic acid production
was measured as described above.
Measurement of lactic acid content and pHe in tumours
and muscle
To avoid the influence of surrounding muscle, second-generation
tumours derived from parental or variant cells that were growing
subcutaneously in mice were used for measurement of lactic acid
and pHe. Studies were performed on subcutaneous tumours when
they had attained a mean weight of -1 g. The concentration of
lactic acid in tumours, serum and muscle was determined using a
commercial lactic acid assay kit (826-A, Sigma). Tumours and
muscle tissue were excised, weighed and homogenized using a
Polytron tissue homogenizer in 5 ml of ice-cold 8% perchloric
acid. The homogenate was centrifuged for 5 min at 200g to
remove debris. Lactic acid content was determined in the resulting
suspension.
Values of pHe in tumours were measured using a miniature
glass electrode (model MI-408b, Microelectrodes, Londonderry,
NH, USA) against a silver/silver chloride reference electrode
(model MI-402, Microelectrodes) using a portable high-imped-
ance pH meter (pH103, Coming). The reference electrode was
inserted subcutaneously on the back of anaesthetized mice distal
from the tumours and the pH electrode was inserted directly into
the tumours or muscle tissue after removal of the overlying skin.
Measurements ofpHe were performed at 50- to 75-,um increments
along a single track at a depth of 3-4 mm into the tumour; a
micrometer was used to manipulate the electrode, which was with-
drawn slightly before each measurement to avoid pressure effects.




Parental cells grew faster than the variant cells in culture, with
doubling times of 21 ± 1 h and 29 ± 2 h respectively (mean +s.e.,
data not shown). Lactate production, glucose consumption and
change in pHe ofmedium containing parental and variant cells are
shown in Figure 1. Variant cells exposed to aerobic or hypoxic
(<10 p.p.m. oxygen) conditions produce almost no lactic acid.
Lactate production of parental cells under aerobic conditions was
5.7 ± 0.2 ,umol h-I 10- cells and increased 1.5-fold under hypoxic
conditions (Figure IA). Variant cells consumed negligible
amounts ofglucose, while the concentration ofglucose in medium
containing parental cells at 106 cells ml decreased after 6 h from
5.5 mm to 2.7 mm and to 2.1 mM under aerobic and hypoxic condi-
tions respectively (Figure 1B). Parental cells acidified exposure
medium, especially when placed under hypoxic conditions,
whereas variant cells caused a minimal change in pHe of the
medium when exposed to either aerobic or hypoxic conditions
(Figure IC). The concentration ofpyruvate in parental and variant
cells was found to be relatively constant and similar for both cell
types for periods up to 24 h (data not shown).
As hypoxic cells may depend on glycolysis for metabolic
energy, we compared the survival of parental and variant cells
under hypoxic conditions. There were no significant differences in
relative plating efficiency between parental and variant cells
exposed to hypoxic conditions for up to 10 h, with surviving frac-
tion (relative to aerobic controls) remaining above 75% (data not
shown). This result is unexpected as the LDH-deficient cells are
expected to depend on aerobic metabolism for their survival and
should become depleted ofATP under hypoxic conditions.
The production ofcarbon dioxide by parental and variant cells is
shown in Table 1. Total production ofcarbon dioxide was 8.8 ± 0.7
and 9.7 ± 0.6gmol h-' 10-7 cells in bicarbonate-free a-MEM with
10% FBS for parental and variant cells respectively. Assays using
14C-labelled glucose and alanine revealed that carbon dioxide
release from glucose by variant cells was about 35% of that by
parental cells, whereas carbon dioxide production from alanine by
variant cells was 2.8 times higher than thatby parental cells. These
differences are highly significant.
In vivo assays
Tumours derived from parental cells grew faster than those from
variant cells in nude mice: doubling times of second-generation
tumours were 6.3 ± 0.5 days and 8.1 ± 0.7 days respectively (data
not shown).
First-generation tumours grown in muscle contained substantial
volumes of necrosis; median percentages of necrosis by volume
were about 75% (range 63-87%) and 58% (range 44-71%) for
variant and parental tumours respectively. After reimplantation of
tumour cells to the dorsum of mice, the percentage of necrosis
decreased to 53% (range 45-60%) and 23% (range 20-25%)
respectively. There was consistently more necrotic tissue in
tumours derived from variant cells that were unable to metabolize
glucose to lactic acid.
Mean values of pHe and of lactate concentration in tumours
derived from parental and variant cells are shown in Table 2.
Parental and variant tumours grown subcutaneously at second
passage were observed to have similar values of pHe 7.03 ± 0.03
Table 1 In vitro carbon dioxide production by parental and variant cells
14CO2 production
Sample Total carbon dioxide From '4C From 14C
production glucose alanine
(gmol 110- cells h-') (c.p.m. 10-7 cells h-1)
Parental 8.8+ 0.7 16 940+ 1020 11 200± 2840
Variant 9.7 ± 0.6 5950 ±500 30 950± 2700
P-value Not significant <0.001 <0.001
Values represent mean ± s.e. from five individual experiments.
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Table 2 Tumour pHe and lactate content in tumour and normal tissue
Sample pHe Lactate content
(,ug g-' of wet weight)
Parental tumours 7.03 ± 0.03a 1877 ± 135d
Variant tumours 7.03 + 0.05b 448 ± 91e
Non-tumour-bearing mice 7.42 + 0.03C 395 + 34'
(Muscle) (Serum)
Values represent mean ± s.e. from five individual tumours. Probability was
calculated using Student's t-test. P-value for a vs c, p< 0.001; b Vs c,


















Figure 2 Lactic acid production by aerobic parental cells (O), original
variant cells (O) and variant cells derived from three tumours at second
passage in mice (A). Cells were placed in a-MEM + 10% FBS buffered with
25 mm bicarbonate at 106 cells ml-'. Points represent mean + s.e. from three
experiments
and 7.03+0.05,respectively, whereas normal muscle had apHe of
7.42 ± 0.03 (mean ± s.e.). The parental and variant tumours were
significantly more acidic than normal tissue (P < 0.001). The
mean values of pHe in viable regions of tumours would be
expected to be lower than the mean values estimatedby microelec-
trodes, as necrotic tissue tends to be slightly alkaline (Kalinowski
and Vaupel, 1988); it is noteworthy that mean pHe in variant
tumours was similar to that in the control tumours, despite ahigher
proportion of necrotic tissue.
Solid tumours derived from parental cells contained elevated
levels of lactic acid compared with those from variant cells
(P < 0.001) and compared with values in normal serum
(P < 0.001). Lactic acid content of tumours derived from variant
cells was similar to that in serum (Table 2).
To determine whether in vivo conditions might select for rever-
tant cells that had regained the ability to produce lactic acid by
glycosis, second-generation tumours grown in mice from variant
cells were excised, and the cells were re-established in culture.
These cultured cells were found to have a rate of production of
lactic acid intermediate between those of the original parental and
variant cells maintained in tissue culture (Figure 2). Thus there is
evidence for partial reversion of the phenotype during growth
under in vivo conditions, even though second-generation tumours
derived from variant cells maintained a much lower content of
lactate (Table 2).
DISCUSSION
The results ofthe present study are consistent with those ofNewell
et al (1993), who used cells with a different metabolic defect, and
suggest that lactate production is not the only and perhaps not the
major cause of tumour acidity.
Parental cells in the present study consumed glucose and
produced lactic acid at substantial rates, and these were increased
under hypoxic conditions. On the contrary, little glucose was used
as a source of metabolic energy by LDH-deficient cells (under
aerobic or hypoxic conditions), as indicated by assays of lactate
and carbon dioxide production. Glucose is converted into pyruvate
through the glycolytic pathway. The amount ofpyruvate generated
by parental and variant cells in tissue culture media was measured
and was found to be relatively constant and similar in both types of
cells. Pyruvate is also derived from metabolism of some amino
acids and can be converted to acetyl-CoA and used in the Krebs
cycle. Our studies of 14CO2 production from labelled glucose and
alanine (Table 1) demonstrate that the parental cells were gener-
ating most of their carbon dioxide (and presumably the precursor
pyruvate) from glucose, while the variant cells were using mainly
amino acids. Although total production of pyruvate and carbon
dioxide were similar in the two sublines under aerobic conditions
in culture, total production of pyruvate and carbon dioxide in
tumours derived from the sublines might be quite different
because of different availability of glucose and amino acids as
substrates.
Many cell types in vitro (and tumour cells in vivo) tend to use
glycolysis as a source of metabolic energy, even under aerobic
conditions. This pathway is a much less efficient process than the
Krebs cycle (two molecules of ATP per molecule of glucose
metabolized to lactate; 36 molecules of ATP per molecule of
glucose metabolized to carbon dioxide via the Krebs cycle). Thus
production of lactic acid by the parental cells may have provided
only a small proportion oftheir metabolic energy, when they were
exposed to aerobic conditions. An unexpected finding in the
current study was the ability of variant cells to tolerate hypoxic
conditions for up to 10 h with minimal loss of plating efficiency.
This result differs from the findings of Newell et al (1993) who
reported cell death of a glycolysis-deficient cell line with a
different metabolic defect when exposed to hypoxic conditions.
Glycolysis-deficient cells are expected to depend on aerobic
metabolism, and presumably cell death under hypoxic conditions
that inhibit energy metabolism will depend on the rate ofdepletion
of ATP, which was not measured directly. A higher rate of cell
death in tumours derived from variant cells is suggested by their
slower growth and greater proportion of necrosis: this might be
due to depletion ofenergy stores under the more chronic hypoxic
conditions that can develop in the solid tumour microenvironment.
LDH-deficient variant cells were not able to produce lactic acid
in culture. Changes in the pHe of the medium after a 6-h incuba-
tion were minimal compared with the parental cells; thus there was
a positive correlation between the amount of lactate production
and fall in pHe ofthe medium. This result supports the hypothesis
that the main cause ofacidification ofculture medium surrounding
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tumour cells is the production of lactic acid by glycolysis. The
total carbon dioxide production in vitro was similar from both
types of cells, and the molar amount of carbon dioxide produced
was higher than that of lactate, even for the parental cells. In
culture, carbon dioxide can escape easily into the air, and carbonic
acid derived from carbon dioxide production does not appear to
have a major influence on the pHe ofthe medium.
Tumours derived from parental cells contained elevated levels
of lactic acid compared with serum. Many other studies have also
recorded high levels of lactate in the extracellular fluid of tumours
(e.g. Gullino et al, 1964; Mueller-Klieser et al, 1988; Kallinowski
et al, 1989). In contrast, the level of lactic acid in tumours derived
from variant cells was much lower than in tumours derived from
parental cells and close to that of serum. There was no significant
difference in the mean value of pHe between parental and variant
tumours, both of which were acidic compared with muscle. This
observation supports the hypothesis that glycolysis leading to the
production of lactic acid is probably not the major mechanism
responsible for tumour acidity, in agreement with previous results
of a study using transformed Chinese hamster lung fibroblasts
(Newell et al, 1993).
Mean values of pHe in the tumours generated in our study
were acidic (pHe 7.03) compared with values in muscle (mean
pHe 7.42) recorded here and with mean values in a variety of
normal tissues (typically pHe 7.4-7.5) recorded in other studies
(e.g. Wike-Hooley et al, 1978). Mean values of pHe in some
human and experimental tumours are lower than those recorded
here (although pHe 6.9-7.0 represents an overall average) and are
known to decrease with increasing distance from tumour blood
vessels (Helmlinger et al, 1997). However, the pH in necrotic
regions of tumours is known to be alkaline (Kallinowski and
Vaupel, 1988). The second-generation tumours on which our
experiments were conducted contained substantial proportions of
necrotic tissue by volume (mean 23% in parental tumours and
53% in variant tumours). Thus, it is likely that mean values ofpHe
in viable components of tumours were lower than 7.03, especially
in those derived from variant cells.
The original variant cells did not produce lactic acid and did not
acidify their exposure medium. Their passage through two genera-
tions of tumours in mice led to acquisition ofthe ability to produce
lactic acid when the cells were regrown in culture, albeit at a lower
rate than parental cells. This observation suggests that glycolysis-
proficient cells may have a growth advantage in vivo, leading to
selection of a revertant phenotype. Despite this partial reversion,
lactic acid concentration in variant tumours at second passage in
mice remained much lower than that in tumours derived from
parental cells and was similar to that in normal serum. The variant
tumours were as acidic as the parental tumours. The lack of corre-
lation between the concentration of lactic acid and pHe indicates
that alternative acid-producing metabolic pathways are present.
Because of the high buffering capacity of cells, only acids
produced in high concentration are likely to reduce pHe in
tumours. Lactic acid and carbonic acid are the major metabolic
products that satisfy this requirement. It is probable, therefore, that
carbon dioxide production by oxidative energy metabolism is a
major cause of tumour acidity. The functional vasculature of
tumours is often inadequate not only to supply the nutritional
needs ofthe expanding population oftumour cells but also to clear
products of metabolism. Under these in vivo conditions, escape of
carbon dioxide from the environment is inhibited, and formation
ofcarbonic acid will result from carbon dioxide production, facili-
tated by the presence ofcarbonic anhydrase: this is in contrast to in
vitro conditions in which carbon dioxide is lost to the surrounding
atmosphere. Gullino et al (1988) have reported increased PCO,
and elevated levels ofdissolved carbon dioxide in rodent tumours,
consistent with the hypothesis that high levels of carbon dioxide
make a substantial contribution to tumour acidity.
The presence of additional factors that contribute to low pH in
avascular regions of tumours is suggested by the recent results of
Parkins et al (1997) who found a decline in extracellular pH after
vascular occlusion of an experimental tumour. The initial decline
in pH correlated with lactate production (under conditions in
which carbon dioxide production was unlikely to occur), but the
subsequent decline in pH was independent of lactate concentra-
tion. It is probable that protons produced by hydrolysis of ATP
caused this further acidification, as the avascular tumour used its
available energy stores.
The present study and that reported previously by our group
(Newell et al, 1993) were designed to complement the many
studies that have shown both an acidic extracellular microenviron-
ment and a high rate of lactic acid in solid tumours. We sought to
determine cause and effect relationships, rather than correlations,
by addressing the hypothesis that tumours derived from cells that
were unable to produce lactate should not be acidic. The contrary
result of Newell et al (1993) was sufficiently surprising that we
believed it important to undertake further experiments with glyco-
lysis-deficient cells of a different phenotype. The results reported
here show also that the production of lactic acid via glycolysis
causes acidification of culture medium, but it is not the only and
probably not the major mechanism responsible for the develop-
ment of an acidic microenvironment within solid tumours. It is, of
course, possible that in each ofthese studies the variant cells cause
tumour acidity by one mechanism and the parental cells by another
(i.e. production oflactic acid), but this seems unlikely. We hypoth-
esize that carbonic acid produced from carbon dioxide exerts a
major role in acidification of the microenvironment of tumours.
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